Ganglioneuroblastoma

Ganglioneuroblastoma is a rare neuroblastic tumor that arises from neural crest cells of the sympathetic nervous system. It is classified as an intermediate form between the benign ganglioneuroma and the malignant neuroblastoma, containing both mature ganglion cells and immature neuroblasts. These tumors most commonly occur in the adrenal glands, posterior mediastinum, retroperitoneum, and along the sympathetic chain, though they can rarely arise in the central nervous system. The ICD-10 code C71.9 references a cerebral location, which represents an exceptionally uncommon presentation. Ganglioneuroblastoma predominantly affects young children, with most cases diagnosed before the age of 5 years. Clinical presentation varies depending on tumor location and extent of disease. Common symptoms include an abdominal or thoracic mass, abdominal pain or distension, weight loss, fatigue, and sometimes neurological symptoms such as weakness or bowel and bladder dysfunction if the tumor compresses the spinal cord. Some patients may present with paraneoplastic syndromes, including opsoclonus-myoclonus syndrome or watery diarrhea due to vasoactive intestinal peptide secretion. Elevated urinary catecholamine metabolites (vanillylmandelic acid and homovanillic acid) are frequently detected and aid in diagnosis. Treatment depends on the tumor's histological subtype (intermixed versus nodular), stage, patient age, and biological markers such as MYCN amplification status. The intermixed subtype generally carries a favorable prognosis and may be managed with surgical resection alone. The nodular subtype behaves more aggressively and may require multimodal therapy including surgery, chemotherapy, and sometimes radiation therapy, similar to treatment protocols used for neuroblastoma. Prognosis is generally better than for neuroblastoma, particularly for the intermixed variant, with many patients achieving long-term survival.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Ganglioneuroblastoma